UBS Report Names LifeNome as one of the Key Players in the Personalized Genomics Market

The UBS evidence lab, in its Genomcis 2.0 report, has identified LifeNome as one of the key players in the emerging personalized genomics market. Alongside with, 23andMe and FamilyTreeDNA, LifeNome was one of the best known brands for individuals who had already done genetic testing.

View more…

WP to LinkedIn Auto Publish Powered By :